专利检索 ap:("Hoffmann-La Roche Inc.") AND inv:"Eva Carina SUM" 第 1 页

1.

发明申请
NOVEL BISPECIFIC ANTIGEN BINDING MOLECULES CAPABLE OF SPECIFIC BINDING TO CD40 AND TO FAP 有权

公开(公告)号：US20210188992A1

公开(公告)日：2021-06-24

申请号：US17179223

申请日：2021-02-18

申请人： Hoffmann-La Roche Inc.

发明人： Peter BRUENKER , Alexander BUJOTZEK , Harald DUERR , Guy GEORGES , Christian KLEIN , Stephane LECLAIR , Moritz RAPP , Eva Carina SUM , Christine TRUMPFHELLER , Pablo UMAÑA

IPC分类号： C07K16/28 , C07K16/40 , A61P35/00

摘要： The invention relates to novel bispecific antigen binding molecules, comprising (a) at least one antigen binding domain capable of specific binding to CD40, and (b) at least one antigen binding domain capable of specific binding to a target cell antigen, in particular Fibroblast Activation Protein (FAP), and to methods of producing these molecules and to methods of using the same.

2.

发明申请
NOVEL BISPECIFIC ANTIGEN BINDING MOLECULES CAPABLE OF SPECIFIC BINDING TO CD40 AND TO FAP 审中-公开

公开(公告)号：US20180340030A1

公开(公告)日：2018-11-29

申请号：US15943821

申请日：2018-04-03

申请人： Hoffmann-La Roche Inc.

发明人： Peter BRUENKER , Alexander BUJOTZEK , Harald DUERR , Guy GEORGES , Christian KLEIN , Stephane LECLAIR , Moritz RAPP , Eva Carina SUM , Christine TRUMPFHELLER , Pablo UMAÑA

IPC分类号： C07K16/28 , A61P35/00

摘要： The invention relates to novel bispecific antigen binding molecules, comprising (a) at least one antigen binding domain capable of specific binding to CD40, and (b) at least one antigen binding domain capable of specific binding to a target cell antigen, in particular Fibroblast Activation Protein (FAP), and to methods of producing these molecules and to methods of using the same.